Cranbury Forum | Bulletin | Info Sharing Â
[Click here to bookmark this page: http://cranbury.info]
â–ª
Cranbury School
â–ª
Cranbury Township
â–ª
Cranbury Library
â–ª
Cranbury.org
â–ª
Cranburyhistory.org
(Press Ctrl and = keys to increase font size)
Search
Register (optional)
Log in to check your private messages
Log in
[http://cranbury.info]
->
News | Events
Post a reply
Username
Subject
Message body
Emoticons
Font colour:
Default
Dark Red
Red
Orange
Brown
Yellow
Green
Olive
Cyan
Blue
Dark Blue
Indigo
Violet
White
Black
Font size:
Tiny
Small
Normal
Large
Huge
Close Tags
[quote="ED K"]Missed opportunity? - Corzine visits RT130 in Cranbury yesterday but doesnt meet with residents. [quote] CRANBURY —Gov. Jon S. Corzine yesterday celebrated the business success of a biopharmaceutical company whose president may run against him next year. Advertisement John Crowley, president of Amicus Therapeutics, became a darling of state and national Republicans this spring when they wanted him to run against U.S. Sen. Frank Lautenberg, D-N.J. He has money and a made-for-the-movies story that Republicans thought could end their three-decade Senate losing streak. Crowley founded a biotech company to develop treatments for two of his children that have Pompe disease, a rare genetic disorder that causes muscular dystrophy. Crowley's tale is the subject of a book that might be made into a movie. Crowley now heads a group that recruits and helps Republican candidates. "I've heard a little bit about you," Corzine said upon arriving at Crowley's company headquarters, which was celebrating hiring its 100th employee, six years after forming with seven in the state Economic Development Authority's business incubator program. Corzine, pleased to meet Crowley, 41, of Princeton said they didn't discuss politics. "I'm not antagonistic, not all of life is about politics," Corzine said. "There are things that are very admirable about what has gone on here at Amicus Therapeutics and John's life story, and I appreciate that just as anyone else would. "We need to make sure that here in New Jersey, we're fully supportive, within the confines of our capacity, financially to support these kinds of companies," Corzine added, saying New Jersey's reputation as being hostile toward business is more perception than reality. But not all politicos are convinced that Wednesday's meeting was all business. "Given all of the governor's invitations, it's interesting that this one was kind of chosen out of the basket as the one that he would attend," said Montclair State University political scientist Brigid Harrison. Crowley, who preferred to focus on his company and employees, said he plans to attend the Republican National Convention in St. Paul, Minn., next month, but that's to promote his party, not himself. "We'll evaluate the opportunities as they come," said Crowley, noting he rejected a Senate run this year because it was such a life-changing decision to make in just a few days. "I have no plans to run for political office. I wouldn't rule anything in or out." Tom Wilson, state chairman of the Republican Party, said the name atop most party leaders' list for 2009 is U.S. Attorney Christopher J. Christie, but if he doesn't run or there's a primary, Crowley could be a strong candidate. "You can't help but be awed by the John Crowley story," Wilson said. "This is somebody who worked every minute of every day to achieve the things he has. . . . This is a guy who has the kind of drive and determination that would be an asset in government, for sure." Amicus, which Crowley expects to have about 120 employees by year's end, was hailed as a success story of New Jersey's economic development initiative because it was the first to hatch from the state's business incubator program. But Crowley agrees with those who complain about the taxes and regulations New Jersey imposes on business. "There are very significant barriers," Crowley said. "We've overcome some of those barriers. . . . I think we can do much much more in the state to promote small business, particularly to grow the life-sciences industry. We have a tremendous competitive advantage in this state that we need to optimize." Contact Gregory J. Volpe:[/quote][/quote]
Options
HTML is
ON
BBCode
is
ON
Smilies are
ON
Disable HTML in this post
Disable BBCode in this post
Disable Smilies in this post
All times are GMT - 4 Hours
Jump to:
Select a forum
Topics
----------------
News | Events
School | Parenting
Blogs by Cranbury Residents
Shopping | Good Deals | Price Talk
Home Sweet Home
House For Sale
Home Sales Pricing Records
Financial | Stocks | Mutual Funds
Cool Bytes & Bits
Garage Sale | ForSale Ads | Things to Trade
Tech Related (PC, Internet, HDTV, etc.)
Interesing and Fun Stuff to Share
What's Your Favorite?
Interests | Hobbies
Cranbury History
Radom Thoughts | Sports | Kitchen Sink
Amazon Deals
Local Business Info
----------------
Local Business Ads (FREE)
Support
----------------
Daily Sponsored Message & Amazon Ads
About Us | Your Privacy | Suggestion | Sponsored
Test Area (Practice your posting skills here)
Topic review
Author
Message
Cranbury Press
Posted: Fri, Aug 15 2008, 1:34 am EDT
Post subject: Governor praises pharmaceutical company
Governor praises pharmaceutical company
Thursday, August 14, 2008 2:52 PM EDT
By Maria Prato-Gaines, Staff Writer
CRANBURY — Gov. Jon Corzine made an appearance in Cranbury on Tuesday afternoon, helping a local biopharmaceutical company celebrate a momentous occasion.
Accompanied by state and local legislators, Gov. Corzine was on hand at Amicus Therapeutics, 6 Cedarbrook Drive, to commemorate the company hiring its 100th employee, a senior clinical research associate.
The company was launched in North Brunswick in 2002 and initially had a staff of seven employees. It later relocated to Cranbury, grew into a Nasdaq-listed public bio-pharmaceutical company and began making strides in the areas of pharmacological chaperones, which are used to treated human genetic diseases.
During his speech, Gov. Corzine described New Jersey as a global medicine chest, and praised the bio-tech industry for its aid in the state’s economic growth.
“We have a competitive advantage, both for the economic benefit to communities and the jobs it creates, but mostly what it provides to the human condition,” Gov. Corzine said. “I congratulate you and all of these folks for what you’re doing.”
Over the years, the company has conducted a number of progressive clinical trials for various genetic diseases including Gaucher, Pompe and Fabry diseases.
For one staff member, this is an effort that hits close to home, as Amicus’ chief executive officer shared his own personal battle against Pompe disease with the more than 100 employees and guests who gathered at the event.
Holding what appeared to be a school assignment from his son, John Crowley read from it: “My hero is my dad. He makes drugs to help people with rare diseases like my brother and my sister.”
Mr. Crowley said that like other families dealing with a genetic disease, his is enthusiastic about the progress scientists have made with treatments in recent years. But he also said that to continue this progress, the quest for better medicine must be driven by great scientists and medical facilities, passion and dedication, not to mention funding.
“To actually see (our drugs) beginning to work in people is the best satisfaction of all,” he said. “We’ve only just begun to fight genetic diseases.”
Some of the other speakers included Caren Franzini from New Jersey’s Economic Development Authority, Diane Edquist Dorman, vice president of public policy for the National Organization for Rare Disorders; and U.S. Rep. Rush Holt.
Mr. Holt, whose district includes Cranbury, Jamesburg and Monroe, encouraged residents to continue to promote the state’s workforce.
“This is just the sort of thing we should be celebrating,” he said. “We should be encouraging entrepreneurs like John Crowley. We have the kind of business and industry that will keep New Jersey growing.”
Following the speeches, both EDA and Amicus representatives exchanged certificates and awards, each congratulating the other for their work in their respective fields.
The two organizations have history together as Amicus was the first company to financially hatch out of the EDA’s business incubator, located in New Brunswick, by moving to its Cranbury location.
“The relationship between Amicus and the EDA began in 2002, when the biopharmeceutical firm moved into lab and office space at the agency’s Commercialization Center for Innovative Technologies — often referred to as its business incubator in North Brunswick,” a press release from Amicus states. “This (100th employee) milestone is likewise significant for the EDA because it showcases what the agency can do to help New Jersey businesses start up.”
For more information on Amicus Therapeutics log onto
www.amicustherapeutics.com.
http://www.packetonline.com/articles/2008/08/14/cranbury_press/news/doc48a47e1e4fac1283049036.txt
ED K
Posted: Thu, Aug 14 2008, 8:46 pm EDT
Post subject: Missed opportunity - Corzine visits RT130 in Cranbury yesterday but doent
Missed opportunity? - Corzine visits RT130 in Cranbury yesterday but doesnt meet with residents.
Quote:
CRANBURY —Gov. Jon S. Corzine yesterday celebrated the business success of a biopharmaceutical company whose president may run against him next year.
Advertisement
John Crowley, president of Amicus Therapeutics, became a darling of state and national Republicans this spring when they wanted him to run against U.S. Sen. Frank Lautenberg, D-N.J. He has money and a made-for-the-movies story that Republicans thought could end their three-decade Senate losing streak.
Crowley founded a biotech company to develop treatments for two of his children that have Pompe disease, a rare genetic disorder that causes muscular dystrophy. Crowley's tale is the subject of a book that might be made into a movie.
Crowley now heads a group that recruits and helps Republican candidates.
"I've heard a little bit about you," Corzine said upon arriving at Crowley's company headquarters, which was celebrating hiring its 100th employee, six years after forming with seven in the state Economic Development Authority's business incubator program.
Corzine, pleased to meet Crowley, 41, of Princeton said they didn't discuss politics.
"I'm not antagonistic, not all of life is about politics," Corzine said. "There are things that are very admirable about what has gone on here at Amicus Therapeutics and John's life story, and I appreciate that just as anyone else would.
"We need to make sure that here in New Jersey, we're fully supportive, within the confines of our capacity, financially to support these kinds of companies," Corzine added, saying New Jersey's reputation as being hostile toward business is more perception than reality.
But not all politicos are convinced that Wednesday's meeting was all business.
"Given all of the governor's invitations, it's interesting that this one was kind of chosen out of the basket as the one that he would attend," said Montclair State University political scientist Brigid Harrison.
Crowley, who preferred to focus on his company and employees, said he plans to attend the Republican National Convention in St. Paul, Minn., next month, but that's to promote his party, not himself.
"We'll evaluate the opportunities as they come," said Crowley, noting he rejected a Senate run this year because it was such a life-changing decision to make in just a few days. "I have no plans to run for political office. I wouldn't rule anything in or out."
Tom Wilson, state chairman of the Republican Party, said the name atop most party leaders' list for 2009 is U.S. Attorney Christopher J. Christie, but if he doesn't run or there's a primary, Crowley could be a strong candidate.
"You can't help but be awed by the John Crowley story," Wilson said. "This is somebody who worked every minute of every day to achieve the things he has. . . . This is a guy who has the kind of drive and determination that would be an asset in government, for sure."
Amicus, which Crowley expects to have about 120 employees by year's end, was hailed as a success story of New Jersey's economic development initiative because it was the first to hatch from the state's business incubator program. But Crowley agrees with those who complain about the taxes and regulations New Jersey imposes on business.
"There are very significant barriers," Crowley said. "We've overcome some of those barriers. . . . I think we can do much much more in the state to promote small business, particularly to grow the life-sciences industry. We have a tremendous competitive advantage in this state that we need to optimize."
Contact Gregory J. Volpe: